Progyny Stock Buy Hold or Sell Recommendation
| PGNY Stock | USD 31.88 0.87 2.66% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Progyny is 'Strong Hold'. Macroaxis provides Progyny buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Progyny positions. The advice algorithm takes into account all of Progyny's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Progyny's buy or sell advice are summarized below:
Real Value 36.68 | Target Price 49.14 | Hype Value 31.83 | Market Value 31.88 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Progyny given historical horizon and risk tolerance towards Progyny. When Macroaxis issues a 'buy' or 'sell' recommendation for Progyny, the advice is generated through an automated system that utilizes algorithms and statistical models.
Progyny |
Execute Progyny Buy or Sell Advice
The Progyny recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Progyny. Macroaxis does not own or have any residual interests in Progyny or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Progyny's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Progyny Trading Alerts and Improvement Suggestions
| Progyny generated a negative expected return over the last 90 days | |
| Progyny is unlikely to experience financial distress in the next 2 years | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from benzinga.com: Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care |
Progyny Returns Distribution Density
The distribution of Progyny's historical returns is an attempt to chart the uncertainty of Progyny's future price movements. The chart of the probability distribution of Progyny daily returns describes the distribution of returns around its average expected value. We use Progyny price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Progyny returns is essential to provide solid investment advice for Progyny.
| Mean Return | -0.24 | Value At Risk | -3.52 | Potential Upside | 2.92 | Standard Deviation | 2.77 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Progyny historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Progyny Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Progyny is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Progyny backward and forwards among themselves. Progyny's institutional investor refers to the entity that pools money to purchase Progyny's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Thrivent Financial For Lutherans | 2023-12-31 | 2.2 M | Riverbridge Partners Llc | 2023-12-31 | 2 M | Geode Capital Management, Llc | 2023-12-31 | 1.8 M | Macquarie Group Ltd | 2023-12-31 | 1.5 M | Northern Trust Corp | 2023-12-31 | 1.4 M | Owls Nest Partners Ia, Llc | 2023-12-31 | 1.4 M | Nuveen Asset Management, Llc | 2023-12-31 | 1.4 M | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1.4 M | Principal Financial Group Inc | 2023-12-31 | 1.4 M | Blackrock Inc | 2023-12-31 | 12.1 M | Vanguard Group Inc | 2023-12-31 | 8.3 M |
Progyny Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 2.3M | 17.1M | 2.9M | (12.6M) | (11.3M) | (10.7M) | |
| Investments | (2.8M) | (39.0M) | 10.9M | (43.9M) | (108.3M) | (102.9M) | |
| Change In Cash | 80.3M | (10.1M) | 21.1M | 28.7M | (22.8M) | (21.6M) | |
| Free Cash Flow | (4.5M) | 35.2M | 23.9M | 77.2M | 185.2M | 194.4M | |
| Depreciation | 2.1M | 1.9M | 1.3M | 1.6M | 2.3M | 2.0M | |
| Other Non Cash Items | 19.8M | 5.6M | 9.8M | 13.8M | 15.6M | 10.1M | |
| Capital Expenditures | 3.0M | 1.0M | 2.1M | 3.2M | 3.6M | 2.2M | |
| Net Income | (8.6M) | 46.5M | 65.8M | 30.4M | 62.0M | 65.1M | |
| End Period Cash Flow | 80.4M | 70.3M | 91.4M | 120.1M | 97.3M | 73.0M | |
| Change To Netincome | 24.9M | (19.5M) | 10.2M | 107.9M | 124.1M | 130.3M |
Progyny Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Progyny or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Progyny's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Progyny stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.33 | |
β | Beta against NYSE Composite | 1.36 | |
σ | Overall volatility | 2.81 | |
Ir | Information ratio | -0.11 |
Progyny Volatility Alert
Progyny exhibits very low volatility with skewness of -2.41 and kurtosis of 11.87. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Progyny's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Progyny's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Progyny Fundamentals Vs Peers
Comparing Progyny's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Progyny's direct or indirect competition across all of the common fundamentals between Progyny and the related equities. This way, we can detect undervalued stocks with similar characteristics as Progyny or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Progyny's fundamental indicators could also be used in its relative valuation, which is a method of valuing Progyny by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Progyny to competition |
| Fundamentals | Progyny | Peer Average |
| Return On Equity | 0.13 | -0.31 |
| Return On Asset | 0.0598 | -0.14 |
| Profit Margin | 0.06 % | (1.27) % |
| Operating Margin | 0.05 % | (5.51) % |
| Current Valuation | 2.81 B | 16.62 B |
| Shares Outstanding | 96.11 M | 571.82 M |
| Shares Owned By Insiders | 1.32 % | 10.09 % |
| Shares Owned By Institutions | 98.68 % | 39.21 % |
| Number Of Shares Shorted | 6.53 M | 4.71 M |
| Price To Earning | 37.91 X | 28.72 X |
| Price To Book | 5.96 X | 9.51 X |
| Price To Sales | 3.03 X | 11.42 X |
| Revenue | 1.09 B | 9.43 B |
| Gross Profit | 167.32 M | 27.38 B |
| EBITDA | 64.47 M | 3.9 B |
| Net Income | 62.04 M | 570.98 M |
| Cash And Equivalents | 122.39 M | 2.7 B |
| Cash Per Share | 1.33 X | 5.01 X |
| Total Debt | 19.39 M | 5.32 B |
| Debt To Equity | 0.03 % | 48.70 % |
| Current Ratio | 2.46 X | 2.16 X |
| Book Value Per Share | 5.78 X | 1.93 K |
| Cash Flow From Operations | 188.81 M | 971.22 M |
| Short Ratio | 6.09 X | 4.00 X |
| Earnings Per Share | 0.62 X | 3.12 X |
| Price To Earnings To Growth | 8.52 X | 4.89 X |
| Target Price | 46.67 | |
| Number Of Employees | 563 | 18.84 K |
| Beta | 1.48 | -0.15 |
| Market Capitalization | 3.15 B | 19.03 B |
| Total Asset | 756.62 M | 29.47 B |
| Retained Earnings | 89.97 M | 9.33 B |
| Working Capital | 454.46 M | 1.48 B |
Note: Disposition of 20627 shares by Mark Livingston of Progyny at 3.95 subject to Rule 16b-3 [view details]
Progyny Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Progyny . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Progyny Buy or Sell Advice
When is the right time to buy or sell Progyny? Buying financial instruments such as Progyny Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 7.4M | 7.7M | 19.4M | 20.4M | Total Assets | 358.1M | 543.0M | 756.6M | 794.5M |
Use Investing Ideas to Build Portfolios
In addition to having Progyny in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Technology Thematic Idea Now
Technology
Companies that are involved in development or distribution of technologically based goods and services such as software, IT or electronics. The Technology theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Technology Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Progyny Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Progyny Stock please use our How to Invest in Progyny guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Progyny Stock analysis
When running Progyny's price analysis, check to measure Progyny's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Progyny is operating at the current time. Most of Progyny's value examination focuses on studying past and present price action to predict the probability of Progyny's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Progyny's price. Additionally, you may evaluate how the addition of Progyny to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Is Progyny's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Progyny. If investors know Progyny will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Progyny listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.645 | Earnings Share 0.62 | Revenue Per Share 11.456 | Quarterly Revenue Growth 0.26 | Return On Assets 0.0598 |
The market value of Progyny is measured differently than its book value, which is the value of Progyny that is recorded on the company's balance sheet. Investors also form their own opinion of Progyny's value that differs from its market value or its book value, called intrinsic value, which is Progyny's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Progyny's market value can be influenced by many factors that don't directly affect Progyny's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Progyny's value and its price as these two are different measures arrived at by different means. Investors typically determine if Progyny is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Progyny's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.